Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Li, Y
Title
Modulation of WNT, Activin/Nodal, and MAPK Signaling Pathways Increases Arterial Hemogenic Endothelium and Hematopoietic Stem/Progenitor Cell Formation During Human iPSC Differentiation.
Citation
Stem cells (Dayton, Ohio); 2023 Jul 14; 41(7) pg685-697
PubMed ID
37220178
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-18
Human
in vitro
300-19
Human
in vitro
First Author
Thomas, G E
Title
The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.
Citation
Nature cell biology; 2022 Jun; 24(6) pg872-884
PubMed ID
35668135
Show Usages
Product Cited
Cross-Reactivity
Applications
300-19
Human
in vitro
200-06
Human
in vitro
300-07
Human
in vitro
300-18
Human
in vitro
200-03
Human
in vitro
First Author
Tvorogov, D
Title
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.
Citation
EMBO reports; 2022 Apr 5; 23(4) pge52904
PubMed ID
35156745
Show Usages
Product Cited
Cross-Reactivity
Applications
300-18
Human
in vitro
300-07
Human
in vitro
300-19
Human
in vitro
200-06
Human
in vitro
200-09
Human
in vitro
First Author
Rice, S
Title
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program.
Citation
Nature communications; 2021 Nov 25; 12(1) pg6905
PubMed ID
34824279
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-19
Human
in vitro
300-18
Human
in vitro
200-02
Human
in vitro
200-07
Human
in vitro
First Author
Marx-Blümel, L
Title
Molecular characterization of hematopoietic stem cells after in vitro amplification on biomimetic 3D PDMS cell culture scaffolds.
Citation
Scientific reports; 2021 Oct 27; 11(1) pg21163
PubMed ID
34707135
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-18
Human
in vitro
300-19
Human
in vitro
First Author
Malyukova, A
Title
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.
Citation
Cell death & disease; 2021 Sep 25; 12(10) pg875
PubMed ID
34564697
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-19
Human
in vitro
300-18
Human
in vitro
First Author
Li, Y
Title
Enhanced self-renewal of human long-term hematopoietic stem cells by a sulfamoyl benzoate derivative targeting p18INK4C.
Citation
Blood advances; 2021 Sep 14; 5(17) pg3362-3372
PubMed ID
34477819
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-18
Human
in vitro
300-19
Human
in vitro
First Author
Araki, D
Title
NOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia.
Citation
Stem cell reports; 2021 Sep 14; 16(9) pg2336-2350
PubMed ID
34450041
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-19
Human
in vitro
300-18
Human
in vitro
First Author
Zoccolillo, M
Title
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency.
Citation
Blood advances; 2021 Aug 24; 5(16) pg3174-3187
PubMed ID
34424322
Show Usages
Product Cited
Cross-Reactivity
Applications
300-07
Human
in vitro
300-18
Human
in vitro
300-19
Human
in vitro
200-03
Human
in vitro
First Author
Boutin, J
Title
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
Citation
Nature communications; 2021 Aug 13; 12(1) pg4922
PubMed ID
34389729
Show Usages
Product Cited
Cross-Reactivity
Applications
300-19
Human
in vitro
300-07
Human
in vitro
300-18
Human
in vitro
200-03
Human
in vitro
200-06
Human
in vitro
showing 10 of 382
Show More